Home » Topics » Regulatory

Regulatory
RSS

Ergo Science's Ergoset enters phase II/III trials in obesity

July 14, 1997

Mylan, Purepac and ESI Lederle report FDA generic approvals

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Generic etodolac approved by FDA

July 11, 1997

Sparta's Spartaject busulfan enters phase I

July 11, 1997

Smoking cessation treatment launched in the U.S.

July 10, 1997

New clinical uses of risperidone investigated

July 10, 1997

Nefazodone evaluated for social phobia

July 10, 1997

Preclinical and clinical antidepressant properties of tolcapone

July 10, 1997

Promising preliminary results from open trial of lamotrigine in depression

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...